Evidence map›Paper›PMID 33893201›Full record

ArticleNeurology2021

Career Development Program for Underrepresented in Medicine Scholars in Academic Neurology: TRANSCENDS.

Raelle Tagge, Daniel T Lackland, Philip B Gorelick, Irene Litvan, Salvador Cruz-Flores, José G Merino, Bruce Ovbiagele

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Health disparities in neurology.Nature reviews. Neurology · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Raelle TaggeFrom the Northern California Institute for Research and Education (R.T.), San Francisco; Department of Neurology (D.T.L.), Medical University of South Carolina, Charleston; Davee Department of Neurology (P.B.G.), Northwestern University School of Medicine, Chicago, IL; Department of Neurosciences (I.L.), University of California San Diego; Department of Neurology (S.C.-F.), Texas Tech, El Paso; Department of Neurology (J.G.M.), Georgetown University, Washington, DC; and Department of Neurology (B.O.), University of California, San Francisco.
Daniel T LacklandFrom the Northern California Institute for Research and Education (R.T.), San Francisco; Department of Neurology (D.T.L.), Medical University of South Carolina, Charleston; Davee Department of Neurology (P.B.G.), Northwestern University School of Medicine, Chicago, IL; Department of Neurosciences (I.L.), University of California San Diego; Department of Neurology (S.C.-F.), Texas Tech, El Paso; Department of Neurology (J.G.M.), Georgetown University, Washington, DC; and Department of Neurology (B.O.), University of California, San Francisco.
Philip B GorelickFrom the Northern California Institute for Research and Education (R.T.), San Francisco; Department of Neurology (D.T.L.), Medical University of South Carolina, Charleston; Davee Department of Neurology (P.B.G.), Northwestern University School of Medicine, Chicago, IL; Department of Neurosciences (I.L.), University of California San Diego; Department of Neurology (S.C.-F.), Texas Tech, El Paso; Department of Neurology (J.G.M.), Georgetown University, Washington, DC; and Department of Neurology (B.O.), University of California, San Francisco.
Irene LitvanFrom the Northern California Institute for Research and Education (R.T.), San Francisco; Department of Neurology (D.T.L.), Medical University of South Carolina, Charleston; Davee Department of Neurology (P.B.G.), Northwestern University School of Medicine, Chicago, IL; Department of Neurosciences (I.L.), University of California San Diego; Department of Neurology (S.C.-F.), Texas Tech, El Paso; Department of Neurology (J.G.M.), Georgetown University, Washington, DC; and Department of Neurology (B.O.), University of California, San Francisco.
Salvador Cruz-FloresFrom the Northern California Institute for Research and Education (R.T.), San Francisco; Department of Neurology (D.T.L.), Medical University of South Carolina, Charleston; Davee Department of Neurology (P.B.G.), Northwestern University School of Medicine, Chicago, IL; Department of Neurosciences (I.L.), University of California San Diego; Department of Neurology (S.C.-F.), Texas Tech, El Paso; Department of Neurology (J.G.M.), Georgetown University, Washington, DC; and Department of Neurology (B.O.), University of California, San Francisco.
José G MerinoFrom the Northern California Institute for Research and Education (R.T.), San Francisco; Department of Neurology (D.T.L.), Medical University of South Carolina, Charleston; Davee Department of Neurology (P.B.G.), Northwestern University School of Medicine, Chicago, IL; Department of Neurosciences (I.L.), University of California San Diego; Department of Neurology (S.C.-F.), Texas Tech, El Paso; Department of Neurology (J.G.M.), Georgetown University, Washington, DC; and Department of Neurology (B.O.), University of California, San Francisco.
Bruce OvbiageleFrom the Northern California Institute for Research and Education (R.T.), San Francisco; Department of Neurology (D.T.L.), Medical University of South Carolina, Charleston; Davee Department of Neurology (P.B.G.), Northwestern University School of Medicine, Chicago, IL; Department of Neurosciences (I.L.), University of California San Diego; Department of Neurology (S.C.-F.), Texas Tech, El Paso; Department of Neurology (J.G.M.), Georgetown University, Washington, DC; and Department of Neurology (B.O.), University of California, San Francisco. bruce.ovbiagele@va.gov.
Medical University of South Carolina · USNorthern California Institute for Research and Education · USGeorgetown University · USTexas Tech University · US

Funding

Training in Research to Assure Neuroscience Scholars Cultivate Expertise in Notable Disparities Science (TRANSCENDS)R25NS098999 · NINDS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI BRUCE OVBIAGELE · 2017 to 2026
$2.5M
NINDS NIH HHS R25 NS098999
6 · The paper itself

Abstract

backgroundThe Training in Research for Academic Neurologists to Sustain Careers and Enhance the Numbers of Diverse Scholars (TRANSCENDS) program is a career advancement opportunity for individuals underrepresented in biomedical research funded by the National Institute of Neurologic Disorders and Stroke and American Academy of Neurology (AAN).

objectiveTo report on qualitative and quantitative outcomes in TRANSCENDS.

designEarly career individuals (neurology fellows and junior faculty) from groups underrepresented in medicine (UIM) were competitively selected from a national pool of applicants (2016-2019). TRANSCENDS activities comprised an online Clinical Research degree program, monthly webinars, AAN meeting activities, and mentoring. Participants were surveyed during and after completion of TRANSCENDS to evaluate program components. OUTCOMES: Of 23 accepted scholars (comprising 4 successive cohorts), 56% were women, 61% Hispanic/Latinx, 30% Black/African American, and 30% assistant professors. To date, 48% have graduated the TRANSCENDS program and participants have published 180 peer-reviewed articles. Mentees' feedback noted that professional skills development (i.e., manuscript and grant writing), networking opportunities, and mentoring were the most beneficial elements of the program. Stated opportunities for improvement included incorporating a mentor-the-mentor workshop, providing more transitional support for mentees in the next stage of their careers, and requiring mentees to provide quarterly reports.

conclusionsTRANSCENDS is a feasible program for supporting UIM neurologists towards careers in research and faculty academic appointments attained thus far have been sustained. Although longer-term outcomes and process enhancements are warranted, programs like this may help increase the numbers of diverse academic neurologists and further drive neurologic innovation.

Identifiers

PMID33893201
PMCPMC8302150
OpenAlexW3155672295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.